Stem Cells Market Size, Share, Trends and Growth Report – Global Opportunities & Forecast, 2023-2030
Stem Cell Market was valued at USD 12.1 billion in 2022 and is forecast to touch USD 27.5 billion in 2030, and the market is expected to grow at a CAGR of 10.8% from 2023-2030.
Overview of the Stem Cell Market Report
Stem cells can also refer to specialized human cells that can reform many different cells from brain cells to muscle cells. They are found in bone marrow, brain, blood vessels, teeth, skin, among others. They have no specific function in the body but helps in faster recovery and treatment and bring versatility with healthier treatment. With the increasing number of clinical trials, the stem cell industry is anticipated to expand over the period of time.
To have an edge over the competition by knowing the market dynamics and current trends of “Stem Cell Market”, request for Sample Report here
Market Dynamic
Stem Cell Market Overview
The stem cell market is experiencing robust growth due to the increase in number of clinical trials across the globe. According to “national Library of Medicine”, the number of clinical trials registered in 2015 were 205,344 and by the end of April 2021, the number has reached to 373,420, which have substantially contributed to the growth of the market. In addition, the stem cell industry has gained importance with the support of government initiatives coupled with the increasing awareness about the advantages of stem cell storage among the people, which has pushed the growth of the market. For instance, in April 2021, the “Australian Government Department of Health”, launched a “Stem Cell Therapies Mission”, in which US$ 150 million will be invested over 9 years for Australians effective treatment, which will strengthen the market. In addition, increasing focus on the treatment of neurological disorders has majorly contributed to expanding the stem cell market. For instance, according to WHO around 7.1% of the total disease burden is neurological and cardiovascular disease, which can be treated by stem cell therapy.
Restraint in the Stem Cell Market
On the contrary, complications in unclear regulatory guidelines for commercialization and preservation of stem cells are expected to hamper the market’s growth.
Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report
Product – Segment Analysis
Based on the product, adult stem cells is expected to dominate the market over the forecast period. The factors contributing to adult stem cells’ growth are tumorigenesis, immune rejection, and minimal controversial issues concerning ethics. In addition, an increasing number of clinical trials have shifted the paddles for the market, leading to the growth of the market.
Application – Segment Analysis
Based on the application, regenerative medicine is expected to grow at a higher CAGR in the market over the forecast period. This is due to the rising number of approvals for different targeted diseases, which has propelled the market. For instance, in 2020 Government of Canada has announced that they will invest US$ 6.9 million in stem cell research which is likely to surge the growth of the market.
In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here
Regional – Segment Analysis:
North America is expected to dominate the global stem cell market over the forecast period. This is due to the strong promotion for the use of cellular therapies for emerging diseases, which has surged the demand for the therapy in United States and Canada. For instance, in 2020 FDA approved a clinical trial that used umbilical cord-derived MSCs for inhibition of the life-menacing lung inflammation in COVID-19 patients, coupled with the strong reimbursement policies in the U.S. leading to the robust growth of the market.
Top Market Players
Various notable players operating in the market, include, Advanced Cell Technology, Inc., STEMCELL Technologies, Inc., BioTime, Inc., Cellular Engineering Technologies Inc., CellGenix GmbH, PromoCell GmbH, Lonza, Kite Pharma, Cellartis AB, Angel Biotechnology, among others.
Key Developments:
-
- In 2019, STEMCELL Technologies, Inc. officially announced the launch of mTeSR Plus a next generation stem cell, which has helped the company in expanding the product portfolio.
Segments Covered in the Report:
The global stem cell market has been segmented based on product, application, technology and regions. Based on product, the market is segmented into adult stem cells (ASCs), human embryonic stem cells, induced pluripotent stem cells (Ipscs) and very small embryonic like stem cells. Based on application, the market is segmented into regenerative medicine and drug discovery and development. Based on technology, the market is segmented into cell acquisition, cell production, cryopreservation and expansion and sub-culture.
For detailed scope of the “Stem Cell Market” report request a Sample Copy of the report
Key questions answered in this research report:
-
- At what pace is global stem cell market growing? What will be the growth trend in the future?
- What are the key drivers and restraints in stem cell market? What will be the impact of drivers and restraints in the future?
- What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global stem cell market?
- Which Product generated maximum revenues in 2019 and identify the most promising Product during the forecast period?
- What are the various Application areas of global stem cell market and how they are poised to grow?
- What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?
|
Report Coverage |
Details |
| Market Revenues (2022) |
USD 12.1 billion |
| Market Base Year |
2022 |
| Market Forecast Period |
2023-2030 |
| Base Year & Forecast Units |
Revenues (USD Billion) |
| Market Segment | By Product, By Application, By Technology, By Region |
| Regional Coverage | Asia Pacific, Europe, North America, and RoW |
| Companies Profiled | Advanced Cell Technology, Inc., STEMCELL Technologies, Inc., BioTime, Inc., Cellular Engineering Technologies Inc., CellGenix GmbH, PromoCell GmbH, Lonza, Kite Pharma, Cellartis AB, Angel Biotechnology, among others; a total of 10 companies covered. |
| 25% Free Customization Available | We will customize this report up to 25% as a free customization to address our client’s specific requirements |
Market Segmentation
Global Stem Cell Market by Product
-
- Adult Stem Cells (ASCs)
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells (Ipscs)
- Very Small Embryonic Like Stem Cells
Global Stem Cell Market by Application
-
- Regenerative Medicine
- Drug Discovery and Development
Global Stem Cell Market by Technology
-
- Cell Acquisition
- Cell Production
- Cryopreservation
- Expansion and Sub-Culture
Global Stem Cell Market by Region
-
-
North America Stem Cell Market (Option 1: As a part of the free 25% customization)
- By Product
- By Application
- By Technology
- US Stem Cell Market All-Up
- Canada Stem Cell Market All-Up
-
Europe Stem Cell Market (Option 2: As a part of the free 25% customization)
- By Product
- By Application
- By Technology
- UK Stem Cell Market All-Up
- Germany Stem Cell Market All-Up
- France Stem Cell Market All-Up
- Spain Stem Cell Market All-Up
- Rest of Europe Stem Cell Market All-Up
-
Asia-Pacific Stem Cell Market (Option 3: As a part of the free 25% customization)
- By Product
- By Application
- By Technology
- China Stem Cell Market All-Up
- India Stem Cell Market All-Up
- Japan Stem Cell Market All-Up
- Rest of APAC Stem Cell Market All-Up
-
RoW Stem Cell Market (Option 4: As a part of the free 25% customization)
- By Product
- By Application
- By Technology
- Brazil Stem Cell Market All-Up
- South Africa Stem Cell Market All-Up
- Saudi Arabia Stem Cell Market All-Up
- UAE Stem Cell Market All-Up
- Rest of world (remaining countries of the LAMEA region) Stem Cell Market All-Up
-
Major Players Operating in the Stem Cell (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)
-
- Advanced Cell Technology, Inc.
- STEMCELL Technologies, Inc.
- BioTime, Inc.
- Cellular Engineering Technologies Inc.
- CellGenix GmbH
- PromoCell GmbH
- Lonza
- Kite Pharma
- Cellartis AB
- Angel Biotechnology
Why GMI Research
